Windlas Healthcare Invests $2 Million in Working Capital to Support Marina Biotech’s Manufacturing Initiatives
August 21, 2017 08:30 ET
|
MARINA BIOTECH, INC
CITY OF INDUSTRY, Calif., Aug. 21, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB:MRNA) (OTCQB:MRNAD) (‘Marina’ or the ‘Company’) a biopharmaceutical company focused on the development and...
Marina Biotech Announces 1-for-10 Reverse Stock Split in Preparation for Proposed Up-Listing of its Common Stock to the NASDAQ Capital Market
August 02, 2017 08:45 ET
|
MARINA BIOTECH, INC
CITY OF INDUSTRY, Calif., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB:MRNA) a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
Marina Biotech Announces Binding Letter of Intent for the Sale of its DiLA2 Delivery Platform
July 25, 2017 12:00 ET
|
MARINA BIOTECH, INC
CITY OF INDUSTRY, Calif., July 25, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB:MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
Marina Biotech Acquires DyrctAxess™ Technology Platform to Support Sales and Marketing of Prestalia®
July 24, 2017 12:00 ET
|
MARINA BIOTECH, INC
CITY OF INDUSTRY, Calif., July 24, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB:MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...
Marina Biotech Announces a License Agreement to SMARTICLES and CRN platforms for Antisense DNA therapeutics
July 19, 2017 12:00 ET
|
MARINA BIOTECH, INC
CITY OF INDUSTRY, Calif., July 19, 2017 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB:MRNA) a biopharmaceutical company focused on the development and commercialization of innovative therapeutics...